Blog Archives

Le Parquet de Paris: le scandale du Mediator (benfluorex) continue

26 mai 2017 – Scandale du Mediator (le benfluorex): le Parquet de Paris demande un procès pour les laboratoires Servier et l’Agence du médicament. Cet antidiabétique, interdit en 2009, est présumé responsable de la mort de centaines de personnes.

Le parquet a annoncé avoir requis un renvoi du groupe pharmaceutique Servier pour \"tromperie aggravée, escroquerie, blessures et homicides involontaires et trafic d\'influence\".Le Parquet a annoncé avoir requis un renvoi du groupe pharmaceutique Servier pour tromperie aggravée,

Read more ›

Tags : , , , , , , , , , , ,

Essai clinique BIA 10-2474 à Rennes : le parquet de Paris ouvre une information judiciaire

Parquet de Paris BIAL I14 juin 2016 – Ce message vient de FranceTV et se reflète dans leur formulation:

Le parquet de Paris ouvre une information judiciaire contre X pour homicide involontaire et blessures involontaires, mardi 14 juin. Un volontaire est mort en janvier 2015 au CHU de Rennes (Ille-et-Vilaine) au cours d’un essai clinique.

Read more ›

Tags : , , , ,

thasso: conditions

thasso: nouveaux tweets

thasso: commentaires récents

View my Flipboard Magazine.

thasso: catégories

thasso: archives

thasso: chat simple

Vous devez être un utilisateur inscrit pour participer à ce tchat.

  • Discovery of new disease-susceptibility gene for steroid-sensitive nephrotic syndrome juillet 3, 2020
    An international research collaboration, including Professor Iijima Kazumoto et al. (of the Department of Pediatrics, Kobe University Graduate School of Medicine) has revealed that NPHS1 is a disease-susceptibility gene for steroid-sensitive nephrotic syndrome in children. The NPHS1 gene encodes nephrin, a component protein for the renal glomerulus slit diaphragm, which prevents protein from being passed […]
  • How digital tools can advance quality and equity in genomic medicine juillet 3, 2020
    The pandemic has forced health care providers to find new ways to connect with patients through screens. For genetic specialists, who provide patients and families with genetic testing for conditions linked to DNA, connecting with patients is an important part of helping them make informed medical decisions.
  • Scientists develop method to reveal the cell types most affected by genetic variation juillet 3, 2020
    Scientists at Johns Hopkins Medicine have found types of cells in the brain that are most susceptible to inherited genetic variants linked to schizophrenia. As a result, their work reveals a shortlist of the variants that most likely impact disease risk.
  • The protein that stands between us and autoimmunity juillet 2, 2020
    The immune system is supposed to protect from external microbial invaders, but sometimes it turns its efforts inward, potentially resulting in autoimmune diseases. In a new study, researchers from Osaka University have discovered how reversible modifications to DNA by certain proteins protect from autoimmune diseases, and conversely, how the absence of these proteins paves the […]
  • Concern following gene therapy adverse events juillet 2, 2020
    The Editor-in-Chief of Human Gene Therapy, the first journal devoted to the field of gene therapy, and one of the world's leading experts on gene therapy have co-authored a new editorial, Moving Forward After Two Deaths in a Gene Therapy Trial of Myotubular Myopathy, in response to the news of two deaths in a now-halted […]